Internal Medicine · Surprise, AZ
NPI
1255398194
Since 2006
Specialty
Internal Medicine
Code 174400000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
12361 W Bola Dr Ste 109
Surprise, AZ, 85378
Phone (623) 227-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
1,551 services
Medicare patients, 2024
414
Average age 72
Drug cost, 2024
$1.6M
3,572 prescriptions
Company payments, 2025
$4,553
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rohit Dwivedi was code 99214 (office e&m - established), 589 times for 278 patients. In total Rohit Dwivedi billed 1,551 services in 16 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 589 | 278 | $80.84 | $48K |
| 99213 Office E&M - Established | Office | 354 | 228 | $55.23 | $20K |
| 93923 Duplex Scan - Extremity Arteries | Office | 138 | 70 | $92.16 | $13K |
| 76536 Ultrasound - Nonspecific | Office | 75 | 70 | $72.62 | $5,447 |
| 99204 Office E&M - New | Office | 74 | 74 | $104.22 | $7,712 |
| 99203 Office E&M - New | Office | 72 | 72 | $74.27 | $5,347 |
| 95923 Electrical Nerve Conductivity | Office | 70 | 69 | $92.99 | $6,509 |
| 95921 Electrical Nerve Conductivity | Office | 68 | 67 | $66.96 | $4,553 |
| 95251 Test - Miscellaneous | Office | 44 | 22 | $26.43 | $1,163 |
| 99215 Office E&M - Established | Office | 33 | 27 | $111.57 | $3,682 |
By year: 2022 $291K for 3,268 services; 2023 $158K for 2,040 services; 2024 $117K for 1,551 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 48 | 45 | $3.25 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Rohit Dwivedi prescribed most often to Medicare patients was Levothyroxine Sodium, with 616 prescriptions and refills. In total Rohit Dwivedi wrote 3,572 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 616 | 1,794 | 211 | $6,677 |
| Metformin Hcl Er Metformin Hcl | 224 | 649 | 92 | $2,689 |
| Synthroid Levothyroxine Sodium | 197 | 511 | 54 | $18K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 170 | 387 | 62 | $27K |
| Mounjaro Tirzepatide | 148 | 200 | 25 | $212K |
| Jardiance Empagliflozin | 130 | 345 | 50 | $202K |
| Metformin Hcl Generic | 123 | 361 | 42 | $1,297 |
| Pioglitazone Hcl Generic | 111 | 325 | 43 | $1,337 |
| Alendronate Sodium Generic | 105 | 276 | 43 | $1,337 |
| Ozempic Semaglutide | 99 | 191 | 33 | $179K |
| Trulicity Dulaglutide | 91 | 128 | 23 | $123K |
| Methimazole Generic | 88 | 263 | 37 | $1,110 |
| Bydureon Bcise Exenatide Microspheres | 83 | 142 | 18 | $120K |
| Glipizide Er Glipizide | 70 | 197 | 28 | $850 |
| Glipizide Generic | 62 | 175 | 19 | $738 |
Brand drugs: 1,865 claims; generic drugs: 1,510 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rohit Dwivedi $4,553 ($4,553 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $2,797.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 8 | $2,797 |
| Amgen Inc. AMGN | 8 | $435 |
| Alexion Pharmaceuticals, Inc. AZN | 11 | $314 |
| Intra-Sana Laboratories | 5 | $186 |
| Pulse Biosciences, Inc. PLSE | 1 | $146 |
| Insulet Corporation PODD | 1 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $91.01 |
| Madrigal Pharmaceuticals MDGL | 1 | $54.34 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $53.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.